Volume 14 Supplement 1

6th International Conference on cGMP: Generators, Effectors and Therapeutic Implications

Open Access

Endothelial dysfunction in a mouse model of human neutral lipid storage disease

  • Astrid Schrammel1Email author,
  • Marion Mussbacher1,
  • Gerald Wölkart1,
  • Heike Stessel1,
  • Günter Hämmerle2,
  • Wael Al Zoughbi3,
  • Gerald Höfler3,
  • Alois Lametschwandtner4,
  • Rudolf Zechner2 and
  • Bernd Mayer1
BMC Pharmacology and Toxicology201314(Suppl 1):P64

DOI: 10.1186/2050-6511-14-S1-P64

Published: 29 August 2013

Background

Systemic knockout of adipose triglyceride lipase (ATGL), the rate-limiting enzyme of triglyceride catabolism, results in a murine phenotype characterized by progressive accumulation of lipids in the heart finally leading to lethal cardiac dysfunction. Since cardiac and vascular dysfunction are closely related we investigated endothelium-dependent and -independent vessel function of ATGL knockout (ATGL(-/-)) mice. Using mice with cardiomyocyte-restricted overexpression of ATGL (cardiac-rescued phenotype;

ATGL(-/-)/MHC-A35) we were able to differentiate between heart-related and -unrelated effects.

Results

Aortic relaxation studies and Langendorff perfusion experiments of isolated hearts demonstrated that ATGL(-/-) mice suffer from pronounced micro- and macrovascular endothelial dysfunction. Experiments with DEA/NO revealed the functional integrity of the smooth muscle cell layer. Since loss in vascular reactivity was restored by ~50 % in cardiac-rescued mice, this phenomenon seems partly a consequence of impaired cardiac contractility. Biochemical analysis revealed that aortic eNOS protein was down-regulated by more than 60% in aortas of ATGL(-/-) mice. As consequence, phosphorylation of VASP at Ser 239 was almost abolished. Both parameters were totally reversed in vessels of cardiac rescued mice. Aortic expression of eNOS mRNA was not affect in ATGL deficiency excluding a transcriptional mechanism underlying the observed effect. Total levels of ubiquitinated proteins (a measure of vascular proteasomal activity) were down-regulated in ATGL-deficient aortas (~26% compared to WT controls) and fully recovered upon cardiomyocyte-restricted overexpression of ATGL.
Figure 1

(A) Aortic relaxation to acetylcholine is blunted in ATGL deficiency and partly recovered in vessels of mice with a cardiac rescued phenotype. (B) Aortic eNOS expression in downregulated in ATGL deficiency an reversed upon cardiac rescue.

Conclusion

Endothelial dysfunction in murine ATGL deficiency partly arises from impaired cardiac contractility and originates from down-regulation of aortic eNOS presumably due to activation of the vascular proteasome. Potential heart-independent mechanisms contributing to the observed defect are currently investigated.

Authors’ Affiliations

(1)
Department of Pharmacology and Toxicology, Institute of Pharmaceutical Sciences, University of Graz
(2)
Department of Molecular Bioscience, University of Graz
(3)
Institute of Pathology, Medical University of Graz
(4)
Department of Cell Biology and Physiology, Vessel and Muscle Research Unit, University of Salzburg

Copyright

© Schrammel et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement